Trading
Please use a PC Browser to access Register-Tadawul
Morgan Stanley Initiates Coverage On MapLight Therapeutics with Overweight Rating, Announces Price Target of $34
Share
MapLight Therapeutics, Inc.
MPLT
19.07
-0.37%